Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

SBC-102 demonstrates safety and clinical activity in patients with LAL deficiency

Sep. 19, 2012

VIVUS launches once-daily Qsymia in the U.S. for weight management

Sep. 19, 2012

New ghrelin receptor antagonists disclosed by Helsinn Healthcare

Sep. 19, 2012

Biodel advances with phase II insulin study

Sep. 17, 2012

Phase III study of Androxal enrolls first patients

Sep. 14, 2012

First phase finishes in endometrial regenerative cell therapy project

Sep. 14, 2012

Zealand Pharma's dual-acting candidate enters phase I trial

Sep. 14, 2012

Galapagos presents promising in vivo results for GLPG-0492

Sep. 13, 2012

New GPR119 receptor agonists patented by LG Life Sciences

Sep. 13, 2012

Eaton Scientific to develop non-hormonal transdermal patch for hot flashes

Sep. 12, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...